Gastroesophageal Reflux Disease GERD Therapeutics Market Report 2023 (Global Edition)

Companies:	AstraZeneca PLC, Eisai Co. Ltd., GlaxoSmithKline PLC, Takeda Pharmaceutical Co. Ltd, Johnson & Johnson, Daewoong Pharmaceutical Co. Ltd, Ironwood Pharmaceuticals Inc., SRS Pharmaceuticals Pvt. Ltd., SFJ Pharmaceuticals
Type:	Antacids , Pro Kinetic Agents, H2 Receptor Blockers, Proton Pump Inhibitors (PPIs)
The base year for the calculation is 2023 and 2018 to 2022 will be historical period. The year 2023 will be estimated one while the forecasted data will be from year 2023 to 2028. When we deliver the report that time we updated report data till the purchase date. Last Updated: 2023-04-15T05:50:32 SKU: CMR283894 Number of Pages: 250+ PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access. Report Format: PDF \| PPT \| Excel \| Word \| Bi Rating: 4.9 Review: 3

COVID-19 Impact and Post Recovery Analysis for Gastroesophageal Reflux Disease GERD Therapeutics Market Report Edition, Data Updated till April 2023 (7th Edition) | Discount Offers Upto 30% + Complimentary Report Access with 3 years Subscription!

Share your contact details to receive free updated sample copy/pages of the recently published edition of Gastroesophageal Reflux Disease GERD Therapeutics Market Report 2023.

Key Insights from Gastroesophageal Reflux Disease GERD Therapeutics Market Report

As per Cognitive Market Research's latest published report, the Global Gastroesophageal Reflux Disease - GERD Therapeutics market size will be $11,904.39 Million by 2029. Gastroesophageal Reflux Disease - GERD Therapeuticsndustry's Compound Annual Growth Rate will be 4.12% from 2023 to 2030.

The North America Gastroesophageal Reflux Disease - GERD Therapeutics market size will be USD 4,158.68 Million by 2029.

Gastroesophageal Reflux Disease GERD Therapeutics Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!

Gastroesophageal Reflux Disease GERD Therapeutics Market Report Description

What is Gastroesophageal Reflux Disease GERD Therapeutics?

GERD (gastroesophageal reflux disease, often known as chronic acid reflux) is a condition in which acid-containing components from the stomach flow back up into the esophagus, the tube connecting the throat to the stomach.

The principal symptoms of GERD are, persistent heartburn and acid regurgitation. Some people have GERD but do not have heartburn. Instead, they experience chest pain, hoarseness in the morning, or trouble swallowing.

GERD is frequently treated with medication and lifestyle changes (like eating habits). There are several over-the-counter and prescription medications available to treat GERD. The majority of over-the-counter drugs are also available in prescription strength.

These medications include over-the-counter antacids, Histamine 2 (H2) blockers, proton pump inhibitors (PPIs), and prokinetic medicines. These medications either decreased the quantity of acid in the stomach or promoted motility (movement) in the upper gastrointestinal system.

Currently, with the changing lifestyle, unhealthy food habits, and other factors many people are suffering from gastroesophageal reflux disease. This raises the demand for gastroesophageal reflux disease drugs.

What is Driving Gastroesophageal Reflux Disease - GERD Therapeutics Market?

Rising prevalence of GERD

Lifestyle and eating habits has been drastically changing all over the world. With the increasing spending capacity, social and peer pressure has led to the adoption of several unhealthy habits such as smoking, alcohol intake, and consumption of unhealthy fatty and fried food.

Moreover, personal and professional life of people is also becoming stressful. Long working hours, improper food consumption and frequently skipping meals or delay in food intake have become new normal across population around the globe.

Major factors aggravate GERD include smoking, eating a large meal, late-night eating habit, unhealthy food such as fatty and fried foods, etc. The consumption of tea, coffee, and alcohol to a wider extent also led to the GERD.

Obesity, smoking, diet, hiatal hernia, and pregnancy are among the potential factors which cause GERD. Data states that the prevalence of obesity tripled between 1975 and 2020. Over 2 billion adults i.e., around 39% of the adult global population were estimated to be overweight of which 600 million are obese.

According to Eurostat, nearly half the population (53%) of Europe are overweight in 2019 of which 36% are considered pre-obese and 17% obese. Obese people are more likely to develop GERD than the normal weight population.

GERD is considered as a chronic disease and has several health-associated impacts. GERD also impacts work quality and productivity of patients. It also decreases the quality of life of patients who are suffering from GERD. The data estimated from research states that about 20 percent of the population in the United States suffers from GERD. Therefore, to improve the personal as well as professional life of people suffering from GERD, treatment becomes mandatory.

Several medications are also potent to trigger or worsen the GERD conditions which include iron supplements, ibuprofen, aspirin, antibiotics, and high blood pressure medication among others. Hence doctors generally prescribe the antacids with this medication which enhances the demand for gastroesophageal reflux disease (GERD) therapeutics.

Hence, the increasing prevalence of GERD drives the growth of the gastroesophageal reflux disease (GERD) therapeutics market.

Restraints for Gastroesophageal Reflux Disease - GERD Therapeutics Market

Availability of alternative treatment options.(Access Detailed Analysis in the Full Report Version)

Opportunities for Gastroesophageal Reflux Disease - GERD Therapeutics Market

Technological innovation in the field of distribution.(Access Detailed Analysis in the Full Report Version)

Timelines can be altered (extra years data or less years data) as per the data needs

Report Timeline and Details

Base Year	2022
Historical Data Time Period	2018-2022
Forecast Period	2023-2030
Report Edition	7th Edition (2023)
Last Update	Last Updated In April 2023
Next Report Edition	June 2023 (Pre-Booking Available)
Market Forecast/Projection Time Period	2023-2030
Report Format	PDF \| PPT \| Excel \| Word \| Bi
Report ID	CMR283894

Gastroesophageal Reflux Disease GERD Therapeutics Market Report 2023 (Global Edition) Table of Content differs according to the user License selection. Current Displayed TOC is for the Single User License Report Edition. TOC Customization options: Add or Remove section/s Or chapter/s from the report. Specific section/s of report can be ordered at a discounted price. If applicable; On Request Volume Data will also be provided (at an Additional Cost).

Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)

This chapter helps you to understand the importance of report and how we designed the report scope of Gastroesophageal Reflux Disease GERD Therapeutics market. As per your requirement we can also design the market scope as a customised report.

Chapter 1 Industrial Insight and Market Scope

1.1 Global Gastroesophageal Reflux Disease GERD Therapeutics Industry Introduction
1.2 Objectives of the Study
1.3 USP of the Report
1.4 Who is this report for?
1.5 Designing of Market Scope
- 1.5.1 Gastroesophageal Reflux Disease GERD Therapeutics Market Segmentation
- 1.5.1 Gastroesophageal Reflux Disease GERD Therapeutics Market Regional Fragmentation
- 1.5.1 Gastroesophageal Reflux Disease GERD Therapeutics Market Players
1.6 Report Duration
1.7 List of Stakeholders

This chapter provides insights on our data collection and data validation process. It covers detailed information on wide range of sources referred during the study.

Chapter 2 Research Methodology Review Complete Research Methodology

2.1 Gastroesophageal Reflux Disease GERD Therapeutics Market Report 2023 Research Methodology
2.2 Systematic Research Approach
- 2.2.1 Primary Research
  - 2.2.1.1 Key Data from Primary
  - 2.2.1.2 Primary Interviews with Experts
  - 2.2.1.3 Key Industry Insights
  - 2.2.1.4 Questionnaire
    
    At Cognitive Market Research, we have designed questionnaire focused on Gastroesophageal Reflux Disease GERD Therapeutics Market for the statistical study. This questionnaire is the key part of our research methodology which is shared with number of Gastroesophageal Reflux Disease GERD Therapeutics industry experts of entire value chain, located across the globe. This study help us to gather accurate quantitative and qualitative data for the final report.
  - 2.2.1.5 Breakdown of Primaries
- 2.2.2 Secondary Research
  - 2.2.2.1 Key Data from Secondary
  - 2.2.2.2 Paid Sources
  - 2.2.2.3 Public Sources
2.3 Market Size Estimation
- 2.3.1 Top-Down Approach
  - 2.3.1.1 Analyzing Market Size by Top-Down Approach (Supply Side)
- 2.3.1 Bottom-UP Approach
  - 2.3.1.1 Analyzing Market Size by Bottom-Up Approach (Demand Side)
2.4 Market Breakdown and Data Triangulation
2.5 Research Assumptions

The executive summary is an overview of a Gastroesophageal Reflux Disease GERD Therapeutics Market Report. In this chapter we have summarized the overall report data in snapshot format.

Chapter 3 Executive Summary of Gastroesophageal Reflux Disease GERD Therapeutics Market

3.1 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Size 2018 – 2030, (USD Million)
3.2 Global Gastroesophageal Reflux Disease GERD Therapeutics Value, Absolute & Opportunity Analysis
3.3 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Y-o-Y Growth Rate Projection by Region (2023 - 2030)
3.4 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Statistics 2022: Snapshot

This chapters incorporated product description overview and regional sales statistics for the year 2018-2030.

Chapter 4 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Overview

4.1 Gastroesophageal Reflux Disease GERD Therapeutics Introduction
4.2 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Statistics by Regions (2018-2030)
- 4.2.1 North America Gastroesophageal Reflux Disease GERD Therapeutics Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.2 Europe Gastroesophageal Reflux Disease GERD Therapeutics Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.3 Asia Pacific Gastroesophageal Reflux Disease GERD Therapeutics Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.4 Latin America Gastroesophageal Reflux Disease GERD Therapeutics Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
- 4.2.5 Middle East and Africa Gastroesophageal Reflux Disease GERD Therapeutics Market Share, Status and Prospect (2018 - 2030) and Value, Absolute & Opportunity Analysis
4.3 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Size (2018-2030)
- 4.3.1 Global Gastroesophageal Reflux Disease GERD Therapeutics Revenue Status and Outlook (2018-2030)
4.4 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Price Analysis by Regions (2018-2030)

This chapter covers a competitive analysis of the global Gastroesophageal Reflux Disease GERD Therapeutics market, and it includes quantitative information such as revenue and market share of the manufacturers. The chapter also includes information regarding the strategies adopted by the manufacturers such as mergers, acquisitions, and new product launches.

Chapter 5 Competitive Analysis (Subject to Availability)

5.1 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Revenue and Share by Manufacturers (2018-2022)
5.2 Global Gastroesophageal Reflux Disease GERD Therapeutics Industry Mergers and Acquisition Analysis
5.3 Global Gastroesophageal Reflux Disease GERD Therapeutics New Launches Analysis
5.4 Company Categorization
5.5 Global Gastroesophageal Reflux Disease GERD Therapeutics Top Winning Strategies, by Manufacturers (2018-2022)

ESG analysis is the consideration of all factors in investment including environmental, social, and governance (ESG) factors. ESG integration is key part of the investment process. ESG analysis helps to measure company’s goals and progress when it comes to climate change, social improvement and good governance.

Chapter 6 Environmental, Social, and Governance (ESG) Analysis

6.1 Overall Company’s Disclosure Score

This chapter helps you understand the Market Drivers, Market Restrain, Market Opportunity and Trends by each segment.

Chapter 7 Qualitative Analysis

7.1 Gastroesophageal Reflux Disease GERD Therapeutics Industrial Dynamics
- 7.1.1 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Drivers
- 7.1.2 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Restrains
- 7.1.3 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Opportunities
- 7.1.4 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Trends
7.2 Gastroesophageal Reflux Disease GERD Therapeutics Market Attractiveness Analysis
- 7.1.1 Market Attractiveness Analysis by Type Segment
- 7.1.2 Market Attractiveness Analysis by Application Segment
7.3 PESTEL Analysis for Gastroesophageal Reflux Disease GERD Therapeutics Market
- 7.3.1 Political Factors
- 7.3.2 Economic Factors
- 7.3.3 Social Factors
- 7.3.4 Technological Factors
- 7.3.5 Legal Factors
- 7.3.6 Environmental Factors
7.4 Porter’s Five Forces Analysis for Gastroesophageal Reflux Disease GERD Therapeutics Market
- 7.4.1 Bargaining Power of Suppliers
- 7.4.2 Bargaining Power of Buyers
- 7.4.3 Threat of Substitutes
- 7.4.4 Threat of New Entrants
- 7.4.5 Degree of Competition
7.5 COVID-19 Impact on Gastroesophageal Reflux Disease GERD Therapeutics Industry
- 7.4.1 Overall Impact of COVID-19 on Gastroesophageal Reflux Disease GERD Therapeutics Industry
- 7.4.2 Post COVID-19 Impact and Recovery Analysis
- 7.4.3 Influencing Factors
7.6 Consumer Preference Analysis for Gastroesophageal Reflux Disease GERD Therapeutics Market
7.7 Patent Analysis of Gastroesophageal Reflux Disease GERD Therapeutics
7.8 Gastroesophageal Reflux Disease GERD Therapeutics Industrial Chain Analysis
7.9 Manufacturing Cost Analysis

This segment of the report provides in-depth and pertinent information on every foremost player in the market through both primary and secondary research. The Company Basic Information, and Sales Area chapter includes ten or more key players, which are dominating the market. Each company profile includes demystifying professional information in a tabular format, which comprises the company’s official website, established year, market position, geographical presence, competitors, and contact information. Further, company profiling includes an in-detailed business overview, COVID-19 impact on the particular firm, product type specifications, revenue & market share, and recent developments done by the company for its inorganic development, such as mergers, strategic acquisitions, partnerships, and others. Besides, profiling includes the company’s investment in research and development activities. The recent innovative product launches, business expansion, investments done by the company in different markets, and other news are also available in the company profiling section. At last, it provides the company’s business strategy and SWOT analysis.

Chapter 8 Company Profiling (Subject to Availability)

This chapter covers in-detailed insights regarding type segments to understand consumer interests and provide a revenue stream for each type. Type segment analysis help in making a better business decision to maximize profitability by focusing resources on those market type that are relatively favorable to their goals.

Chapter 9 Global Gastroesophageal Reflux Disease GERD Therapeutics Market by Type Segmentation Analysis (2018-2030)

9.1 Detailed Qualitative Analysis
9.2 Global Gastroesophageal Reflux Disease GERD Therapeutics Revenue and Share (%) by Type (2018-2030)
- 9.2.1 Antacids Market Size
  - 9.2.1.1 Global Antacids Market Share and Revenue (USD Million) for 2018-2030
  - 9.2.1.2 Gastroesophageal Reflux Disease GERD Therapeutics Market for Antacids , by Country (2021 Vs 2024)
- 9.2.2 Pro Kinetic Agents Market Size
  - 9.2.2.1 Global Pro Kinetic Agents Market Share and Revenue (USD Million) for 2018-2030
  - 9.2.2.2 Gastroesophageal Reflux Disease GERD Therapeutics Market for Pro Kinetic Agents, by Country (2021 Vs 2024)
- 9.2.3 H2 Receptor Blockers Market Size
  - 9.2.3.1 Global H2 Receptor Blockers Market Share and Revenue (USD Million) for 2018-2030
  - 9.2.3.2 Gastroesophageal Reflux Disease GERD Therapeutics Market for H2 Receptor Blockers, by Country (2021 Vs 2024)
- 9.2.4 Proton Pump Inhibitors (PPIs) Market Size
  - 9.2.4.1 Global Proton Pump Inhibitors (PPIs) Market Share and Revenue (USD Million) for 2018-2030
  - 9.2.4.2 Gastroesophageal Reflux Disease GERD Therapeutics Market for Proton Pump Inhibitors (PPIs), by Country (2021 Vs 2024)

This chapter categorizes detailed perceptions into an application segment based on end users’ needs, and preferences to understand their requirements and purchasing patterns effectively. It analyzes the current trends of the market that mainly consists of information related to new product use, trends in consumer demand, and available close substitutes of the product.

Chapter 10 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Regional Analysis

10.1 Detailed Qualitative Analysis
10.2 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Revenue by Region (2018-2030)
10.3 Global Gastroesophageal Reflux Disease GERD Therapeutics Market Share (%) by Region (2018-2030)

Chapter 11 North America Gastroesophageal Reflux Disease GERD Therapeutics Market Outlook (2018 - 2030)

Chapter 12 Europe Gastroesophageal Reflux Disease GERD Therapeutics Market Outlook (2018 - 2030)

Chapter 13 Asia Pacific Gastroesophageal Reflux Disease GERD Therapeutics Market Outlook (2018 - 2030)

Chapter 14 Latin America Gastroesophageal Reflux Disease GERD Therapeutics Market Outlook (2018 - 2030)

Chapter 15 Middle East and Africa Gastroesophageal Reflux Disease GERD Therapeutics Market Outlook (2018 - 2030)

This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Gastroesophageal Reflux Disease GERD Therapeutics market

Chapter 16 Research Findings

16.1 Key Takeaways
16.2 Analyst Point of View

We not only deliver the published report but only provide customized data on request to make your customized report edition (Exclusively Delivered and not shared on the website/Other Clients). The following additional data and delivery depend on Data Availability, Client's Data Request, Additional Charges Applied, etc.

Customize the Report Edition (Is applicable, On Request, Subject to Data Available, At an Additional Cost)

Segmentation Level Customization	Additional Segments and Sub Segment Cross-split Segments of Gastroesophageal Reflux Disease GERD Therapeutics Additional Countries Granular data
Global level Data Customization	Sales Volume Production Production Capacity Pricing Analysis of Product
Region level Data Customization	Sales Volume Production Production Capacity Pricing Analysis of Product
Country level Data Customization	Sales Volume Production Production Capacity Segment Analysis on Country level is also available (On request) Pricing Analysis of Product
Company Level	Company Market Share on Regional Level/ Country Level Company Sales Volume Company Production Volume Company Production Capacity Company Specific Distributors Manufacturing Process by different manufacturers Global/ Regional/ Country level Major Distributors Additional Competitors Analysis of your choice Tier 1 tier 2 tier 3 start ups.... Manufacturers Market Concentration Ratio Industry benchmarking
Additional Data Analysis	Surveys/polls Value Chain Analysis Raw Material Analysis Price Trend Analysis Supplier/Distributor List Market Economic Supply Demand Gap Analysis Customer Sentiment Analysis Stock Price Prediction Analysis Stock Performance Correlation Analysis Patent Analysis Technology Development Analysis Merger and Acquistion Consulting Top Winning Strategies / Strategic Benchmarkeing Heat Map Analysis ESG Analysis Product life cycle Customer buying behavior and decision-making process Marketing Mix Analysis Product Launch Strategy Building
Additional Qualitative Data	Pipeline Products Market Trends Industry Events and Developments Sales Key Indicators Risk Analysis Regulatory Landscape Customer Sentiment Analysis R&D landscape Market Entry / Exit Consulting Identifying New Application/End Use
Additional Quantitative Data	Import Data Export Data Quarterly Revenue (Q1,Q2,Q3,Q4) Forecast Period Extension: 2023 to 2033 Historical Period Data Available: 2011 to 2022 IPO prospectus
Service Level Customization	Quarterly Report Updates (Q1,Q2,Q3,Q4) Annual Report Updates (Subscribe 1/2/3/4/...Years) Exclusive Report Delivery (NDA) Dedicated Research Analyst Support (Email, Calls, Interview) Data Support (Unlimited Time Period) Gastroesophageal Reflux Disease GERD Therapeutics Database Subscription (Full Access)
Report Format Alteration	Quarterly Revenue (Q1,Q2,Q3,Q4) Revenue in USD ($)/Euro (€)/Pound (£)/Yen (¥)/etc Translation Rights and Multi Language Report Editions Average FOB Price/Average Selling Price

We have various report editions of Gastroesophageal Reflux Disease GERD Therapeutics Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Gastroesophageal Reflux Disease GERD Therapeutics Market Analysis

Global Gastroesophageal Reflux Disease GERD Therapeutics Market Report 2023 talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Gastroesophageal Reflux Disease GERD Therapeutics Industry growth. Gastroesophageal Reflux Disease GERD Therapeutics market has been segmented with the help of its Type, , and others. Gastroesophageal Reflux Disease GERD Therapeutics market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.

Report scope is customizable as we have a huge database of Gastroesophageal Reflux Disease GERD Therapeutics industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.

Industry segmentation can be altred as per your needs. For example, we can proivde cross slipt between Antacids with , , additional country analysis, volume/consumption data, etc.

Gastroesophageal Reflux Disease GERD Therapeutics Market Report Scope

Major Type Analysed	Antacids Pro Kinetic Agents H2 Receptor Blockers Proton Pump Inhibitors (PPIs)
Top Manufacturers Disclosed	AstraZeneca PLC Eisai Co. Ltd. GlaxoSmithKline PLC Takeda Pharmaceutical Co. Ltd Johnson & Johnson Daewoong Pharmaceutical Co. Ltd Ironwood Pharmaceuticals Inc. SRS Pharmaceuticals Pvt. Ltd. SFJ Pharmaceuticals Confidential Data Access The Paid Version Data Hidden List of 2nd tier, 3rd tier and new players (data available) Please Note: Not all players are disclosed \| Listed In No particular Order due to Data Confidentiality
Global, Regional and Country Analysis	North America (United States, Canada, Mexico) Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium) Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC) South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America) Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)
Key Qualitative Information Covered	Drivers Restraints Opportunities COVID-19 Impact Analysis Key Trends Technological Advancement

Gastroesophageal Reflux Disease GERD Therapeutics Market,by type

Antacids

The Antacids segment Revenue will be USD 5,110.59 Million by 2029.

Antacids are medications that neutralize stomach acid to treat indigestion and heartburn. They are available as a liquid or as pills. Antacids are accessible without a prescription at pharmacies and supermarkets. It often includes calcium carbonate, magnesium hydroxide, aluminium hydroxide, and/or sodium bicarbonate.Some antacids with alginates as an active ingredient are also available in the market. These alginates are available as Alginic Acid and sodium alginate. Some of these antacids include Rennie Duo, Algycon Tablet, Peptac Liquid, Gaviscon, and many others.

Pro Kinetic Agents

The Prokinetic agents are also known as prokinetics. These are drugs that helps in the treatment of acid reflux. Prokinetics serve to tighten the lower esophageal sphincter (LES) and induce the stomach contents to evacuate more quickly. For instance, Metoclopramide (Reglan) is one of the prokinetic drug which work by increasing gastrointestinal muscle activity.

H2 Receptor Blockers

H2 receptor blockers are medications that treat gastroesophageal reflux disease (GERD). H2 receptor blocker drugs assist in the alleviating heartburn symptoms through lowering the amount of stomach acid secreted by glands in the stomach lining. Some of the H2 receptor blocker drugs such as Famotidine (Pepcid), Cimetidine (Tagamet), Nizatidine (Axid), and others are available in the market.

Proton Pump Inhibitors (PPIs)

PPIs are the type of drug that can be used to lower stomach acid and treat GERD symptoms. PPIs function by inhibiting and lowering stomach acid production. This allows for any injured esophageal tissue to recover. PPIs also assist to prevent heartburn, which is a common symptom of GERD.

Gastroesophageal Reflux Disease GERD Therapeutics Market Share (%) by Type in 2018-2030

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Gastroesophageal Reflux Disease GERD Therapeutics Industry. Request a Free Sample PDF!

Segment Analysis of Gastroesophageal Reflux Disease GERD Therapeutics Market

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities for each application of Gastroesophageal Reflux Disease GERD Therapeutics from 2018 to 2030. This will also help to analyze the demand for Gastroesophageal Reflux Disease GERD Therapeutics across different end-use industries. Our research team will also help acquire additional data such as Value Chain, Patent analysis, Company Evaluation Quadrant (Matrix), and much more confidential analysis and data insights.

Some of the key of Gastroesophageal Reflux Disease GERD Therapeutics are:

Gastroesophageal Reflux Disease GERD Therapeutics Market Share (%) by in 2018-2030

The above Graph is for representation purposes only. This chart does not depict actual Market share. Please purchase the Gastroesophageal Reflux Disease GERD Therapeutics market report 2023 Edition by contacting our team.

Gastroesophageal Reflux Disease GERD Therapeutics Market Regional Analysis

Region and country analysis section of Gastroesophageal Reflux Disease GERD Therapeutics Industry Analysis has been segmented into 5 major region such as North America, Europe, Asia Pacific, Middle East & Africa ,and Latin America (along with respective major contributing countries) and provides the revenue share, current trends.

The base years considered for all the estimations by analyzing trends and growth rate will help you gain an in-depth understanding of the conclusions provided in this report. This report also includes figures, graphs, pie charts, tables and bar graphs that explain the data analysis based on current trends at the country level as well as key regions. This research report also focuses on assessing factors such as profit, product price, capacity, production, supply demand market growth rate along with others to create a clear picture on the future prospects of Gastroesophageal Reflux Disease GERD Therapeutics market.

Region-wise, the market is analyzed across: (In case you wish to acquire a specific region or any country data then please contact us)

North America (United States, Canada, Mexico)
Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

Gastroesophageal Reflux Disease GERD Therapeutics Market Share (%) by Region (2018-2030)

The above graph is for illustrative purposes only. To learn more about geographical trends request the free sample pages. Contact US!

Company Profile

AstraZeneca

AstraZeneca is biopharmaceutical company, which is engaged in the development and supply of prescription medicine for diverse range of therapeutical areas. The company offers wide range products under different therapies such as oncology, biopharmaceuticals, cardiovascular, renal, metabolism, respiratory, immunology, rare disease and others. The company offers different products in pipeline across different therapies such as vaccine, immune therapies, rare disease, respiratory, immunology, cardiovascular, renal, metabolism, and oncology segment AstraZeneca has launched Nexium, Proton pump inhibitor for treatment of GERD in 2000. Later the company supplied Nexium to Pfizer under OTC product. The company offers Enhertu Destiny Gastric 01 product approved by US, EU and Japan agencies. The drug works on HER 2-targeting antibody drug conjugate. This pipeline product is suitable for patient with advanced gastric or gastroesophageal junction with adenocarcinoma patients, on two prior regimens.

RECENT NEWS

October 2019

AstraZeneca has sold commercial rights to German pharma Cheplapharm Arzeneimittel GmbH

AstraZeneca had sold its commercial rights of LOsec omeprazole for $243 million to German pharma Cheplapharm Arzeneimittel GmbH. This product used in treatment of acid reflux.

GlaxoSmithKline PLC- (GSK GROUP OF COMPANIES)

GlaxoSmithKline is healthcare-based company, which has several subsidiaries operating in the market. The company offers three segments, prescription medicines, vaccines and consumer healthcare products. GSK Group of companies offers Gaviscon for treatment of GERD disease, which shows signs of heart burn and indigestion. The company has diverse range of pipeline products in phase I, II and III trails across infectious, HIV, Oncology, respiratory, and other therapies.

RECENT NEWS

February 2022

GSK collaborated with Sanofi to gain regulatory authorization for COVID-19 vaccine

GSK has engaged in collaboration with Sanofi, in order to gain the regulatory authorization for vaccines in the pandemic

July 2019

GlaxoSmithKline has acquired Pfizer Consumer Health business

GlaxoSmithKline has engaged in acquisition of Pfizer consumer health segment. This acquisition approved by European commission. This acquisition expanded OTC product line such as antacids, laxatives, vitamins, supplements and other.

Top Companies Market Share in Gastroesophageal Reflux Disease GERD Therapeutics Industry: (In no particular order of Rank)

AstraZeneca PLC
Eisai Co. Ltd.
GlaxoSmithKline PLC
Takeda Pharmaceutical Co. Ltd
Johnson & Johnson
Daewoong Pharmaceutical Co. Ltd
Ironwood Pharmaceuticals Inc.
SRS Pharmaceuticals Pvt. Ltd.
SFJ Pharmaceuticals
Confidential Data
Access The Paid Version
Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables..

Author's Conclusion

The Global Gastroesophageal Reflux Disease - GERD Therapeutics Market revenue in 2017: USD 7,634.54 Million
Antacids held for largest share of total revenue generated in 2020
The increasing prevalence of GERD and easy access to OTC medication and the presence of the generic drug in the market drive the growth of the gastroesophageal reflux disease (GERD) therapeutics market.
The adoption of natural and home remedies, and the availability of alternative treatment options may hinder the growth of the gastroesophageal reflux disease (GERD) therapeutics market.
Technological innovation in the field of distribution of medicines is expected to create lucrative opportunities for the gastroesophageal reflux disease (GERD) therapeutics market.

Author's Detail

Surabhi Bhaiyya, LinkedIn

Senior Research Analyst at Cognitive Market Research

Surabhi Bhaiyya is an experienced market researcher focused on the Pharma & Healthcare industry. With over 7+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry. To get in touch and access the above report book an apointment at https://calendly.com/speak-to-analyst.

Research Methodology Implemented by Author

1.1 Primary Research for Gastroesophageal Reflux Disease GERD Therapeutics Market
- 1.1.1 Modes of Primary Research:
1.2 Secondary Research for Gastroesophageal Reflux Disease GERD Therapeutics Market
1.3 Market Estimation for Gastroesophageal Reflux Disease GERD Therapeutics Market
1.4 Data Triangulation for Gastroesophageal Reflux Disease GERD Therapeutics Market
1.5 Questionnaire for Gastroesophageal Reflux Disease GERD Therapeutics Market

Preview Full Research Methodology

Key Questions Answered By Gastroesophageal Reflux Disease GERD Therapeutics Market Report 2023

Why Antacids have a significant impact on Gastroesophageal Reflux Disease GERD Therapeutics market?

What are the key factors affecting the Antacids and Pro Kinetic Agents of Gastroesophageal Reflux Disease GERD Therapeutics Market?

What is the CAGR/Growth Rate of during the forecast period?

By type, which segment accounted for largest share of the global Gastroesophageal Reflux Disease GERD Therapeutics Market?

Which region is expected to dominate the global Gastroesophageal Reflux Disease GERD Therapeutics Market within the forecast period?

Frequently Asked Questions (FAQs)

What is the estimated revenue of The Global Gastroesophageal Reflux Disease - GERD Therapeutics Market?

The Global Gastroesophageal Reflux Disease - GERD Therapeutics Market is estimated to reach USD 11,904.39 Million by the end of 2029.

What is the CAGR of The Global Gastroesophageal Reflux Disease - GERD Therapeutics Market?

The Global Gastroesophageal Reflux Disease - GERD Therapeutics Industry's Compound Annual Growth Rate will be 4.12% from 2023 to 2030.

Who are the top key players operating in The Global Gastroesophageal Reflux Disease - GERD Therapeutics Market?

AstraZeneca PLC, Eisai Co. Ltd., GlaxoSmithKline PLC, Takeda Pharmaceutical Co. Ltd, Johnson & Johnson, Daewoong Pharmaceutical Co. Ltd, Ironwood Pharmaceuticals Inc., SRS Pharmaceuticals Pvt. Ltd., SFJ Pharmaceuticals are the key players operating in the market.

Which is the fastest growing type segment of The Global Gastroesophageal Reflux Disease - GERD Therapeutics Market?

Proton Pump Inhibitors (PPIs) are expected to register a Compound Annual Growth Rate of 3.73% within the forecast period.

Which region held the largest revenue share of The Global Gastroesophageal Reflux Disease - GERD Therapeutics Market?

In terms of revenue, North America dominated the region with 34.63% of the total market in 2022.

What is included in the Gastroesophageal Reflux Disease GERD Therapeutics Market Report Access?

Measures to Explore Untapped Market
Understanding Market Dynamics
Understanding Changing Economics
Competitors Market Share
Global/Region/Country Level Analysis
Identify Upcoming End Use Industries
Global Price Trend Analysis

Value Chain Analysis
Customer Sentiment/Need Analysis
Identification of Key Growth Segments
Industry Upstream and Downstream Analysis
Raw Material Sourcing and Cost Analysis
Identify Key Customers Across Globe
Concept Development and Market Testing
Merger-Acquisition Strategy

Reasons to Purchase the Gastroesophageal Reflux Disease GERD Therapeutics Market Report 2023 (Global Edition)?

The research study and report are been made exclusively for an institution or person who is strategizing to build a business or strategically wants to expand certain portfolio.
This report will help in analyzing complete market scenario across the globe who wish to expand their current business or is willing to invest in some profitable sector.

This report will prove beneficial for person or an organization who wish to be updated regarding their business environment, consumers’ behaviour, and their requirements. The environment is constantly changing, and in such scenario, this report will help in understanding market parameters through 360-degree view.
The report is thus ideal for KOL, CEO's, CFO's, directors, and others. It is also helpful to senior executives, business development managers, marketing managers, and consultants. Furthermore, government bodies, agencies and other kind of organizations can also leverage our report to understand market.

Objective of Publishing Gastroesophageal Reflux Disease GERD Therapeutics Market Report 2023

Our objective for the Gastroesophageal Reflux Disease GERD Therapeutics market is to help in making imperative business decisions, securing investments, determining new business opportunities in the market. Further, the report helps to analyze overall marketing needs of customers, and avoid business failures.
To know the potential market size and growth rate before launching a new product line. The report in a way helps in designing R&D budget wisely by estimating maximum total profit.

To identify the Gastroesophageal Reflux Disease GERD Therapeutics market dynamics, industrial insights, and economic progression for critical information about the market conditions and specific business landscape.
To assess the overall competitive landscape of a particular business sector and to provide complete analysis in regards with various external factors impacting the market growth.
To create a strong foundation for building a strategy and foster insight into market conditions so that market players can make better business decisions. Besides, we aim to provide a complete portfolio of the major players involved the market.
To define the scope which will further help in creating new products that will surpass the gap between current offerings and customers’ needs.
To help in revealing significant clues concerning buying habits, regional culture, lifestyle, and population density that plays an integral role in shaping market behavior.
To strategically analyze micro markets with respect to individual growth trends, prospects, and contributions to the total market.

USPs and Service Differentiators

Competitors Analysis: We provide data from the supplier side covering key details such as market share split among 1st tier, 2nd tier, and 3rd tier, Emerging Players, and Start-Ups. (whereas most of our competitors published data for top-tier companies)
We provide market revenue share not only for Public listed companies but also the privately listed companies.

Country Analysis: The Country level market split analysis is part of the report hence the data granularity is provided.
We have been closely working with the Top 500 Fortune businesses, our clientele spanning 20+ industries. Our clientele is a mix of investors, manufacturers, end-users, distributors, etc. With our data subscription model (Athenaeum) 70% of clients have already subscribed/purchased reports for multiple years which helped us achieve unbelievable client retention statistics.
Product + Service: In terms of the product we deliver the report access (PDF+ PPT+ EXCEL+ Cloud+ POWER BI) whereas in terms of service; we provide data support where a dedicated research analyst will be assigned and add-on benefits. (Whereas most of our competitors believe only in delivering the data/report and service and support remain questionable.)
Credibility and Data Accuracy: We deliver accuracy close to 90-95% with the help of our in-house research team, freelancer, and industry expert network, sources present worldwide. This Data is backed up by strong What are our clients saying about our services.

	Student User License (PDF File): This license allows student to gain the access of the report at an exceptionally discointed price, Company profiles, Company Market Share will not be the part of deliverable report (Since this a confidential data hence respective chapters will not be shared with student/s and respective user license selection). To know more, email us. Student User License	Data Pack : This is Quantitative Data (Excel Sheet) which presents Numeric Data, Graphs and Charts which can help to easily access the complete numerical data shared in our report. without any additional cost) Data Pack	Single User License (PDF File): The purchase of a 'Single User License' grants access to a specific report for one person only and must not be shared with other employees within the same company. know more and compare USer license Options Single User	Multi or Team User License (PDF File): (2 to 10 persons/employees) \| The purchase of a 'Multi User License’ grants access to a specific report for a team of two to five users only within the same department or within the same company. Multi/Team User	Corporate User License (PDF File): Unlimited User/Employees) \| The purchase of a 'Corporate License’ grants access to a specific report to whole company and its wide audience. This includes subsidiary companies or other companies within a group of companies. Corporate User	Athenaeum Subscription Athenaeum Subscription
	Report format can be PDF encrypted file, PPT, Excel, Online copy, Power Bi etc. Access
Report format can be PDF encrypted file, PPT, Excel, Online copy, Power Bi etc. Access	Student Report Edition	Excel Sheet	PDF + Excel File	PDF + Excel File + Cloud	PDF + Excel + PPT + BI + Cloud + User Dashboard	Access to Gastroesophageal Reflux Disease GERD Therapeutics DATABASE + Other Relevent Markets
	Number of users who can utilize the report data User Access
Number of users who can utilize the report data User Access	Restricted Print, Copy, Paste & Download (Paid Download)	Restricted Print, Copy, Paste & Download (Paid Download)	Limited to 1 User	Limited to Team	Unlimited Users	Unlimited Users
	We update our reports on the basis of either Quarterly Updates or on Client's Request Future Updates
We update our reports on the basis of either Quarterly Updates or on Client's Request Future Updates	Paid	Paid	Paid	Paid	Free (3 Years Validity)	Unlimited Validity
	This report is available for Quarterly Updates or on Client's Request, we suggest please kindly purchase Corporate User License Quarterly Updates
This report is available for Quarterly Updates or on Client's Request, we suggest please kindly purchase Corporate User License Quarterly Updates	X	X	X	X	Free Quarterly Industry Update	Free Quarterly Industry Update
	You can subscribe to either report or the whole industry. Our sales execute will guide you more regarding this option Subscription
You can subscribe to either report or the whole industry. Our sales execute will guide you more regarding this option Subscription	NA	$945.00	$945.00	$945.00	Free	Unlimted
	You can customize the report user license according to your requirements. Add Ons
You can customize the report user license according to your requirements. Add Ons	✔	✔	✔	✔	✔	✔
	You can Upgrade the report user license according to your requirements. License Upgrade
You can Upgrade the report user license according to your requirements. License Upgrade	✔	✔	✔	✔	✔	✔
You can print the report copy with additional charges. we suggest please kindly purchase Corporate User License for unlimited report print copies. Print Access
You can print the report copy with additional charges. we suggest please kindly purchase Corporate User License for unlimited report print copies. Print Access	NA	Free	Free	Free	Free	Unlimted
Data Pack : This is Quantitative Data (Excel Sheet) which presents Numeric Data, Graphs and Charts which can help to easily access the complete numerical data shared in our report. without any additional cost) Data Pack
This is a QUANTITATIVE DATA only, which includes but is not restricted to numeric data, tables, and charts. Data Pack (Add-On)	$645.00 USD	Included	Included	Included	Included	Unlimted
	$945.00 or Request Demo	$1,845.00 or Request Data Pack Sample	$2,445.00 or Request Report Sample	$4,545.00 or Request Report Sample	$6,845.00 or Request Report Sample	Starts from $10,000* USD or Request Demo

Gastroesophageal Reflux Disease GERD Therapeutics Market Report 2023 (Global Edition)

Key Insights from Gastroesophageal Reflux Disease GERD Therapeutics Market Report

Gastroesophageal Reflux Disease GERD Therapeutics Market Report Description

What is Gastroesophageal Reflux Disease GERD Therapeutics?

What is Driving Gastroesophageal Reflux Disease - GERD Therapeutics Market?

Rising prevalence of GERD

Restraints for Gastroesophageal Reflux Disease - GERD Therapeutics Market

Availability of alternative treatment options.(Access Detailed Analysis in the Full Report Version)

Opportunities for Gastroesophageal Reflux Disease - GERD Therapeutics Market

Technological innovation in the field of distribution.(Access Detailed Analysis in the Full Report Version)

Table of Content (Revenue USD Edition), (Enquire about Volume/Consumption Edition Data)

Gastroesophageal Reflux Disease GERD Therapeutics Market Analysis

Gastroesophageal Reflux Disease GERD Therapeutics Market,by type

Antacids

Pro Kinetic Agents

H2 Receptor Blockers

Proton Pump Inhibitors (PPIs)

Gastroesophageal Reflux Disease GERD Therapeutics Market Share (%) by Type in 2018-2030

Segment Analysis of Gastroesophageal Reflux Disease GERD Therapeutics Market

Gastroesophageal Reflux Disease GERD Therapeutics Market Share (%) by in 2018-2030

Gastroesophageal Reflux Disease GERD Therapeutics Market Regional Analysis

Gastroesophageal Reflux Disease GERD Therapeutics Market Share (%) by Region (2018-2030)

Company Profile

AstraZeneca

RECENT NEWS

AstraZeneca has sold commercial rights to German pharma Cheplapharm Arzeneimittel GmbH

GlaxoSmithKline PLC- (GSK GROUP OF COMPANIES)

RECENT NEWS

GSK collaborated with Sanofi to gain regulatory authorization for COVID-19 vaccine

GlaxoSmithKline has acquired Pfizer Consumer Health business

Author's Conclusion

Author's Detail

Research Methodology Implemented by Author

Key Questions Answered By Gastroesophageal Reflux Disease GERD Therapeutics Market Report 2023

Frequently Asked Questions (FAQs)

How to Purchase the Full Report Access of Gastroesophageal Reflux Disease GERD Therapeutics Market Report 2023

NEED ASSISTANCE?

WRITE AN EMAIL

CALL US

Request Sample

Report Type